Free Access
Reprod. Nutr. Dev.
Volume 44, Number 6, November-December 2004
Page(s) 509 - 538
References of Reprod. Nutr. Dev. 44 509-538
  1. Sprecher H. An update on the pathways of polyunsaturated fatty acid metabolism. Curr Opin Clin Nutr Metab Care 1999, 2: 135-138.
  2. Galli D, Agradi E, Paoletti R. The (n-6) pentaene:(n-3) hexaene fatty acid ratio as an index of linolenic acid deficiency. Biochim Biophys Acta 1974, 369: 142-145.
  3. Wheeler TG, Benolken RM, Anderson RE. Visual membranes: specificity of fatty acid precursors for the electrical response to illumination. Science 1975, 188: 1312-1314.
  4. Bourre JM, François M, Youyou A, Dumont O, Piciotti M, Pascal G, Durand G. The effects of dietary $\alpha$-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rat. J Nutr 1989, 119: 1880-1892 [PubMed].
  5. Neuringer M, Connor WE, Van Petten C, Barstad L. Dietary $\omega$-3 fatty acid deficiency and visual loss in infant Rhesus monkeys. J Clin Invest 1984, 73: 272-276 [PubMed].
  6. Neuringer M, Connor W, Lin DS, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal n-3 fatty acid deficiency on retina and brain in Rhesus monkeys. Proc Natl Acad Sci USA 1986, 83: 4021-4025.
  7. Moriguchi T, Sheaff-Greiner R, Salem N Jr. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 2000, 75: 2563-2573.
  8. Jeffrey BG, Mitchell DC, Gibson RA, Neuringer M. n-3 Fatty acid deficiency alters recovery of the rod photoresponse in Rhesus monkeys. Invest Ophthalmol Vis Sci 2002, 43: 2806-2814 [PubMed].
  9. Connor WE, Neuringer M. The effects of n-3 fatty acid deficiency and repletion upon the fatty acid composition and function of the brain and retina. Prog Clin Biol Res 1988, 282: 275-294.
  10. Diau GY, Loew ER, Wijendran V, Sarkadi-Nagy E, Nathanielsz PW, Brenna JT. Docosahexaenoic and arachidonic acid influence on preterm baboon retinal composition and function. Invest Ophthalmol Vis Sci 2003, 44: 4559-4566.
  11. Uauy RD, Birch DG, Birch EE, Tyson JE, Hoffman DR. Effect of dietary $\omega$-3 fatty acids on retinal function of very-low-birth-weight neonates. Pediatr Res 1990, 28: 485-492 [PubMed].
  12. Birch D, Birch E, Hoffman D, Uauy R. Retinal development in very-low-birth-weight infants fed diets differing in $\omega$-3 fatty acids. Invest Ophthalmol Vis Sci 1992, 33: 2365-2376 [PubMed].
  13. Birch E, Birch D, Hoffman D, Hale L, Everett M, Uauy R. Breast-feeding and optimal visual development. J Pediatr Ophthalmol Strabismus 1993, 30: 33-38.
  14. Lauritzen L, Hansen HS, Jùrgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 2001, 4: 1-94.
  15. Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 1994, 60: 189-194 [PubMed].
  16. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol 2000, 42: 174-181.
  17. Hoffman DR, Birch EE, Castaneda YS, Fawcett SL, Wheaton DH, Birch DG, Uauy R. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr 2003, 142: 669-677.
  18. Connor W, Neuringer M, Reisbick S. Essential fatty acids: the importance of n-3 fatty acids in the retina and brain. Nutr Rev 1992, 50: 21-29.
  19. Salem N Jr, Wegher B, Mena P, Uauy R. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci USA, 1996, 93: 49-54.
  20. Uauy R, Mena P, Wegher B, Nieto S, Salem N Jr. Long chain polyunsaturated fatty acid formation in neonates: effect of gestational age and intrauterine growth. Pediatr Res 2000, 47: 127-135.
  21. Pawlosky RJ, Hibbeln JR, Novotny JA, Salem N Jr. Physiological compartmental analysis of $\alpha$-linolenic acid metabolism in adult humans. J Lipid Res 2001, 42: 1257-1265 [PubMed].
  22. Maurage C, Guesnet P, Pinault M, Rochette de Lempdes J, Durand G, Antoine J, Couet C. Effect of two types of fish oil supplementation on plasma and erythrocyte phospholipids in formula-fed term infants. Biol Neonate 1998, 74: 416-429.
  23. Cunnane SC, Francescutti V, Brenna JT, Crawford MA. Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids 2000, 35: 105-111.
  24. Gibson RA, Neumann MA, Makrides M. Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr 1997, 51: 578-584.
  25. Guesnet P, Antoine J-M, Rochette de Lempdes J-B, Galent A, Durand G. Polyunsaturated fatty acid composition of human milk in France: changes during the course of lactation and regional differences. Eur J Clin Nutr 1993, 47: 700-710.
  26. Alessandri JM, Goustard B, Guesnet P, Durand G. Polyunsaturated fatty acids status in blood, heart, liver, intestine, retina and brain of newborn piglets fed either sow milk or a milk replacer diet. Reprod Nutr Dev 1996, 36: 95-109 [PubMed].
  27. Goustard-Langelier B, Guesnet P, Durand G, Antoine JM, Alessandri JM. n-3 and n-6 fatty acid enrichment by dietary fish oil and phospholipid sources in brain cortical areas and nonneural tissues of formula-fed piglets. Lipids 1999, 34: 5-16 [PubMed].
  28. Alessandri JM, Goustard B, Guesnet P, Durand G. Docosahexaenoic acid concentrations in retinal phospholipids of piglets fed an infant formula enriched with long-chain polyunsaturated fatty acids: effects of egg phospholipids and fish oils with different ratios of eicosapentaenoic acid to docosahexaenoic acid. Am J Clin Nutr 1998, 67: 377-385.
  29. Alessandri JM, Poumès-Ballihaut C, Langelier B, Perruchot MH, Raguénez G, Lavialle M, Guesnet P. Incorporation of docosahexaenoic acid into nerve membrane phospholipids: bridging the gap between animals and cultured cells. Am J Clin Nutr 2003, 78: 702-710.
  30. Legrand P, Bourre JM, Descomps B, Durand G, Renaud S. Lipides. In: Martin A (Ed), Apports nutritionnels conseillés pour la population française, AFSSA 3e ed, Tec & Doc, 2001, p 63-82.
  31. Beaufrère B, Briend A, Ghisolfi J, Goulet O, Putet G, Rieu D, Turck D, Vidailhet M. Nourrissons, enfants et adolescents. In: Martin A (Ed), Apports nutritionnels conseillés pour la population française, AFSSA 3e ed, Tec & Doc, 2001, p 255-291.
  32. Galli C. Commentary on the workshop statement. Essentiality of and recommended dietary intake of Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot Essent Fat Acids 2000, 63: 127-129.
  33. Simopoulos AP, Leaf A, Salem N Jr. Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot Essent Fat Acids 2000, 63: 119-121.
  34. Innis SM. Human milk and formula fatty acids. J Pediatr 1992, 120: S56-S61.
  35. Guesnet P, Couet C, Alessandri JM, Antoine JM, Durand G. Variabilité de la teneur en acide linoléique (18:2n-6) et du rapport 18:2n-6/18:3n-3 des lipides dans le lait de femme en France. Ann Pédiatr (Paris) 1995, 42: 282-288.
  36. Chulei R, Xiaofang L, Hongsheng M, Xiulan M, Guizheng L, Gianhong D, DeFrancesco CA, Connor WE. Milk composition in women from five different regions of China: the great diversity of milk fatty acids. J Nutr 1995, 125: 2993-299.
  37. Combes N, Boué C. Apports alimentaires en acides linoléique et $\alpha$-linolénique d'une population aquitaine. OCL 2001, 8: 118-121.
  38. Djoussé L, Hunt SC, Arnett DK, Province MA, Eckfeldt JH, Ellison RC. Dietary linolenic acid is inversely associated with plasma triacylglycerol: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2003, 78: 1098-1102 [PubMed].
  39. Meyer BJ, Mann NJ, Lewis JL, Milligan GC, Sinclair AJ, Howe PR. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003, 38: 391-398.
  40. Voskuil DW, Feskens EJM, Katan MB, Kromhout D. Intake and sources of $\alpha$-linolenic acid in Dutch elderly men. Eur J Clin Nutr 1996, 50: 784-787 [PubMed].
  41. Johansson LRK, Solvoll K, Bjornboe GEA, Drevon CA. Intake of very long-chain n-3 fatty acids related to social status and lifestyle. Eur J Clin Nutr 1998, 52: 716-721.
  42. Astorg P, Arnault N, Czernichow S, Noisette N, Galan P, Hercberg S. Dietary intakes and food sources of n-6 and n-3 polyunsaturated fatty acids in French adult men and women. Lipids (in press).
  43. Welch AA, Lund E, Amiano P, Dorronsoro M, Brustad M, Kumle M et al. Variability of fish consumption within the 10 European countries participating in the European Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2002, 5: 1273-1285.
  44. Hulshof KFAM, van Erp-Baart MA, Anttolainen M, Becker W, Church SM, Couet C, Hermann-Kunz E, Kesteloot H, Leth T, Martins I. Intake of fatty acids in Western Europe with emphasis on trans fatty acids: the TRANSFAIR study. Eur J Clin Nutr 1999, 53: 143-157.
  45. Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996, 31 (Suppl): S157-S161.
  46. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H. Fatty acid composition in major depression: decreased $\omega$3 fractions in cholesteryl esters and increased C20:4$\omega$6/C20:5$\omega$3 ratio in cholesteryl esters and phospholipids. J Affect Disord 1996, 38: 35-46 [CrossRef] [PubMed].
  47. Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998, 43: 315-319.
  48. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998, 48: 149-155.
  49. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered $\omega$3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999, 85: 275-291 [CrossRef] [PubMed].
  50. De Vriese SR, Christophe AB, Maes M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-3PUFAs are related to major depression. Life Sci 2003, 73: 3181-3187.
  51. Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 2003, 121: 109-122.
  52. Chiu CC, Huang SY, Su KP, Lu ML, Huang MC, Chen CC, Shen WW. Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol 2003, 13: 99-103.
  53. Glen AIM, Glen EMT, Horrobin DF, Vaddadi KS, Spellman M, Morsefisher N, Ellis K, Shinner FS. A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophr Res 1994, 12: 53-61.
  54. Peet M, Laugharne J, Rangarajan N, Horrobin D, Reynolds G. Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients. J Psychiatr Res 1995, 29: 227-232.
  55. Fenton WS, Hibbeln J, Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 2000, 47: 8-21 [CrossRef] [PubMed].
  56. Khan MM, Evans DR, Visayasudha G, Scheffer RE, Parikh VV, Mahadik SP. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first episode of psychosis and after years of treatment with antipsychotics. Schizophr Res 2002, 58: 1-10.
  57. Arvindakshan M, Sitasawads S, Debsikdar V, Ghate M, Evans D, Horrobin DF, Bennett C, Ranjekar PK, Mahadik SP. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizoprenia patients. Biol Psychiatry 2003, 53: 56-64.
  58. Burgess JR, Stevens L, Zhang W, Peck L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr 2000, 71: 327S-330S.
  59. Vancassel S, Durand G, Bartélémy C, Lejeune B, Martineau J, Guilloteau D, Andrès C, Chalon S. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fat Acids 2001, 65: 1-7.
  60. Hibbeln JR. Fish consumption and major depression. Lancet 1998, 351: 1213.
  61. Hibbeln JR. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 2002, 69: 15-29 [CrossRef] [PubMed].
  62. Noaghiul S, Hibbeln JR. Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry 2003, 160: 2222-2227.
  63. Hirayama T. Life-style and mortality: a large census-based cohort study in Japan. Ed Karger, Basel, 1990.
  64. Huan M, Hamazaki K, Sun Y, Itomura M, Liu H, Kang W, Watanabe S, Terasawa K, Hamazaki T. Suicide attempt and n-3 fatty acid levels in red blood cells: a case-control study in China. Biol Psychiatry 2004, 56: 490-496.
  65. Tanskanen A, Hibbeln JR, Hintikka J, Haatainen K, Honkalampi K, Viinamaki H. Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry 2001, 58: 512-513 [PubMed].
  66. Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H, Lehtonen J, Vartiainen E. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 2001, 52: 529-531.
  67. Silvers KM, Scott KM. Fish consumption and self-reported physical and mental health status. Public Health Nutr 2002, 5: 427-431.
  68. Timonen M. Horrobin D, Jokelainen J, Laitinen J, Herva A, Räsänen P. Fish consumption and depression: the Northern Finland 1966 birth cohort study. J Affect Disord 2004, 82: 447-452.
  69. Suzuki S, Akechi T, Kobayashi M, Taniguchi K, Goto K, Sasaki S, Tsugane S, Nishiwaki Y, Miyaoka H, Uchitomi Y. Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer. Br J Cancer 2004, 90: 787-793.
  70. Mamalakis G, Tornaritis M, Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fat Acids 2002, 6: 311-318.
  71. Mamalakis G, Kiriakakis M, Tsibinos G, Kafatos A. Depression and adipose polyunsaturated fatty acids in the survivors of the seven countries study population of Crete. Prostaglandins Leukot Essent Fat Acids 2004, 70: 495-501.
  72. Tiemeyer H, van Thuil HR, Hofman A, Kiliaan AJ, Breteler MMB. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 2003, 78: 40-46.
  73. Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J. Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 2004, 161: 567-569.
  74. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002, 159: 477-479.
  75. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002, 59: 913-919.
  76. Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE Jr, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord 2003, 5: 310-319.
  77. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial, Arch Gen Psychiatry 1999, 56: 407-412.
  78. Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder: a preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003, 13: 267-271 [CrossRef] [PubMed].
  79. Zanarini MC, Frankenburg MD. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry 2003, 160: 167-169 [CrossRef] [PubMed].
  80. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003, 160: 996-998 [CrossRef] [PubMed].
  81. Llorente AM, Jensen CL, Voigt RG, Fraley JK, Berretta MC, Heird WC. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am. J Obstet Gynecol 2003, 188: 1348-1353.
  82. Peet M, Brind J, Ramchand CN, Shah S, Vankar GK. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr Res 2001, 49: 243-251.
  83. Peet M, Horrobin DF, in association with the E-E Multicentre Study Group. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res 2002, 36: 7-18.
  84. Emsley RA, Myburgh CC, Oosthuizen PP, Van Rensburgh SJ. Randomised placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry 2002, 159: 1596-1598.
  85. Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatr 2002, 26: 233-239.
  86. Ayton AK, Azaz A, Horrobin DF. A pilot open case series of ethyl-EPA supplementation in the treatment of anorexia nervosa. Prostaglandins Leukot Essent Fat Acids 2004, 71: 205-209.
  87. Horrobin DF, Jenkins K, Bennett CN, Christie WW. Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding. Prostaglandins Leukot Essent Fat Acids 2002, 66: 83-89.
  88. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000, 35: 1305-1312 [PubMed].
  89. Tully AM, Roche HM, Fallon C, Bruce I, Lawlor B, Coakley D, Gibney MJ. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr 2003, 89: 483-489.
  90. Heude B, Ducimetière P, Berr C. Cognitive decline and fatty acid composition of erythrocyte membranes - The EVA Study. Am J Clin Nutr 2003, 77: 803-808.
  91. Kalmijn S, van Boxtel MPJ, Ocke M, Verschuren WMM, Kromhout D, Launer LJ. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004, 62: 275-280.
  92. Kalmijn S, Launer LJ, Ott A, Witteman JCM, Hofman A, Breteler MB. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol 1997, 62: 275-280.
  93. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, Aggarwal N, Schneider J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003, 60: 940-946.
  94. Barberger-Gateau P, Letenneur L, Deschamps V, Pérès K, Dartigues JF, Renaud S. Fish, meat, and risk of dementia: cohort study. Br Med J 2002, 325: 932-933.
  95. Nordvik I, Myhr KM, Nyland H, Bjerve KS. Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 2000, 102: 143-149.
  96. Schlanger S, Shinitsky M, Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 2002, 43: 103-104.
  97. Puri BK, Bydder GM, Counsell SJ, Corridan BJ, Richardson AJ, Hajnal JV, Appel C, Mckee HM, Vaddadi KS, Horrobin DF. MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment. Neuroreport 2002, 13: 123-126.
  98. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka JI, Shido O. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 2002, 81: 1084-1091.
  99. Bazan NG. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res 2003, 44: 2221-2233.
  100. Blanc EM, Keller JN, Fernandez S, Mattson MP. 4-Hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 1998, 22: 149-160 [CrossRef] [PubMed].
  101. Tong W, Shah D, Xu J, Diehl JA, Hans A, Hannink M, Sun GY. Involvement of lipid mediators on cytokine signaling and induction of secretory phospholipase A2 in immortalized astrocytes (DITNC). J Mol Neurosci 1999, 12: 89-99.
  102. Jump DB. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 2002, 277: 8755-8758.
  103. Petroni A, Salami M, Blasevich M, Papini N, Galli C. Inhibition by n-3 fatty acids of arachidonic acid metabolism in a primary culture of astroglial cells. Neurochem Res 1994, 19: 1187-1193.
  104. Gordon-Bell J, Tocher DR, Sargent JR. Effect of supplementation with 20:3(n-6), 20:4(n-6) and 20:5(n-3) on the production of prostaglandins E and F of the 1-, 2- and 3-series in turbot (Scophthalmus maximus) brain stroglial cells in primary culture. Biochem Biophys Acta 1994, 1211: 335-342.
  105. Galli C, Marangoni F, Petroni A. Modulation of arachidonic acid metabolism in cultured rat astroglial cells by long-chain n-3 fatty acids. Adv Exp Med Biol 1992, 318: 115-120.
  106. Champeil-Potokar G, Denis I, Goustard- Langelier B, Alessandri JM, Guesnet P, Lavialle M. Astrocytes in culture require docosahexaenoic acid to restore the n-3/n-6 polyunsaturated fatty acid balance in their membrane phospholipids. J Neurosci Res 2004, 75: 96-106.
  107. Newman EA. New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci 2003, 26: 536-542.
  108. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, Bazan NG. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003, 278: 43807-43817.
  109. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci USA 2004, 101: 8491-8496.
  110. Lee A. Membrane structure. Curr Biol 2001, 11: R811-R814.
  111. Mayor S, Rao M. Rafts: scale-dependent, active lipid organization at the cell surface. Traffic 2004, 5: 231-240 [CrossRef] [PubMed].
  112. DeMar JC Jr, Rundle DR, Wensel TG, Anderson RE. Heterogeneous N-terminal acylation of retinal proteins. Prog Lipid Res 1999, 38: 49-90.
  113. Litman BJ, Mitchel DC. A role for phospholipid polyunsaturation in modulating membrane protein function. Lipids 1996, 31S: S193-S197.
  114. Litman BJ, Niu SL, Polozova A, Mitchell DC. The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction. J Mol Neurosci 2001, 16: 237-242.
  115. Polozova A, Litman BJ. Cholesterol dependent recruitment of di22:6-PC by a G protein-coupled receptor into lateral domains. Biophys J 2000, 79: 2632-2643.
  116. Mitchell DC, Niu SL, Litman BJ. Optimization of receptor-G protein coupling by bilayer lipid composition I. Kinetics of rhodopsin-transducin binding. J Biol Chem 2001, 276: 42801-42806.
  117. Niu SL, Mitchell DC, Lim SY, Wen ZM, Kim HY, Salem N Jr, Litman BJ. Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J Biol Chem 2004, 279: 31098-31104.
  118. Yao PJ. Synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer's disease. Trends Neurosci 2004, 27: 24-29.
  119. Zimmer L, Delion-Vancassel S, Durand G, Guilloteau D, Bodard S, Besnard JC, Chalon S. Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 2000, 41: 32-40.
  120. Zimmer L, Vancassel S, Cantagrel S, Breton P, Delamanche S, Guilloteau D, Durand G, Chalon S. The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am J Clin Nutr 2002, 75: 662-667.
  121. Aïd S, Vancassel S, Poumès-Ballihaut C, Chalon S, Guesnet P, Lavialle M. Effect of a diet-induced (n-3) polyunsaturated fatty acid depletion on cholinergic parameters in the rat hippocampus. J Lipid Res 2003, 44: 1545-1551.
  122. Kodas E, Galineau L, Bodard S, Vancassel S, Guilloteau D, Besnard JC, Chalon S. Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J Neurochem 2004, 89: 695-702.
  123. Delion S, Chalon S, Herault J, Guilloteau D, Besnard JC, Durand G. Chronic dietary $\alpha$-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr 1994, 124: 2466-2476.
  124. Chalon S, Vancassel S, Zimmer L, Guilloteau D, Durand G. Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids 2001, 36: 937-944.
  125. Ximenes da Silva A, Lavialle F, Gendrot G, Guesnet P, Alessandri JM, Lavialle M. Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. J Neurochem 2002, 81: 1328-1337.
  126. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990, 347: 645-650.
  127. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 1997, 94: 4318-4323.
  128. Zhang B, Marcus SL, Sajjadi FG, Alvares K, Reddy JK, Subramani S, Rachubinski RA, Capone JP. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc Natl Acad Sci USA 1992, 89: 7541-7545.
  129. Desvergne B, Ijpenberg A, Devchand PR, Wahli W. The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling. J Steroid Biochem Mol Biol 1998, 65: 65-74.
  130. Marcus SL, Miyata KS, Zhang B, Subramani S, Rachubinski RA, Capone JP. Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc Natl Acad Sci USA 1993, 90: 5723-5727.
  131. Moreno S, Farioli-Vecchioli S, Cerù MP. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 2004, 123: 131-145.
  132. Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, Desvergne B. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 2001, 142: 4195-4202.
  133. Holst D, Luquet S, Nogueira V, Kristiansen K, Leverve X, Grimaldi PA. Nutritional regulation and role of peroxisome proliferator-activated receptor $\delta$ in fatty acid catabolism in skeletal muscle. Biochim Biophys Acta - Mol Cell Biol Lipids 2003, 1633: 43-50.
  134. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, Watanabe M, Magoori K, Ioka RX, Tachibana K, Watanabe Y, Uchiyama Y, Sumi K, Iguchi H, Ito S, Doi T, Hamakubo T, Naito M, Auwerx J, Yanagisawa M, Kodama T, Sakai J. Activation of peroxisome proliferator-activated receptor $\delta$ induces fatty acid $\beta$-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 2003, 100: 15924-15929 [CrossRef] [PubMed].
  135. Langelier B, Furet JP, Perruchot MH, Alessandri JM. Docosahexaenoic acid membrane content and mRNA expression of acyl-CoA oxidase and of peroxisome proliferator-activated receptor-$\sigma$ are modulated in Y79 retinoblastoma cells differently by low and high doses of $\alpha$-linolenic acid. J Neurosci Res 2003, 74: 134-141 [CrossRef] [PubMed].
  136. Saluja I, Granneman JG, Skoff RP. PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture. Glia 2001, 33: 191-204.
  137. McCaffery PJ, Adams J, Maden M, Rosa-Molinar E. Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci 2003, 18: 457-472.
  138. Kassam A, Winrow CJ, Fernandez-Rachubinski F, Capone JP, Rachubinski RA. The peroxisome proliferator response element of the gene encoding the peroxisomal-oxidation enzyme enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase is a target for constitutive androstane receptor/9-cis-retinoic acid receptor-mediated transactivation. J Biol Chem 2000, 275: 4345-4350.
  139. Samuel W, Kutty RK, Nagineni S, Gordon JS, Prouty SM, Chandraratna RAS, Wiggert B. Regulation of stearoyl coenzyme A desaturase expression in human retinal pigment epithelial cells by retinoic acid. J Biol Chem 2001, 276: 28744-28750.
  140. Whitney KD, Watson MA, Collins JL, Benson WG, Stone TM, Numerick MJ, Tippin TK, Wilson JG, Winegar DA, Kliewer SA. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol Endocrinol 2002, 16: 1378-1385.
  141. Mata de Urquiza M, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000, 290: 2140-2144 [CrossRef] [PubMed].
  142. Fan YY, Spencer TE, Wang N, Moyer MP, Chapkin RS. Chemopreventive n-3 fatty acids activate RXR$\alpha$ in colonocytes. Carcinogenesis 2003, 24: 1541-1548 [CrossRef] [PubMed].
  143. Lengqvist J, De Urquiza AM, Bergman AC, Wilson TM, Sjovall J, Perlmann T, Griffiths WJ. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand binding domain. Mol Cell Proteomics 2004, 3: 692-703.
  144. Berger A, Mutch DM, German JB, Roberts MA. Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids Health Dis 2002, 1: 1-23.
  145. Kitajka K, Puskas LG, Zvara A, Hackler L, Barcelo-Coblijn G, Yeo YK, Farkas T. The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci USA 2002, 99: 2619-2624.
  146. Barcelo-Coblijn G, Kitajka K, Puskas LG, Hogyes E, Zvara A, Hackler L, Farkas T. Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. Biochim Biophys Acta 2003, 1632: 72-79.
  147. Bracelo-Coblijn G, Hogyes E, Kitajka K, Puskas LG, Zvara A, Hacker L, Nyakas C, Penke Z, Farkas T. Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci USA 2003, 100: 11321-11326.
  148. Rojas CV, Martinez JI, Flores I, Hoffman DR, Uauy R. Gene expression analysis in human fetal retinal explants treated with docosahexaenoic acid. Invest Ophthalmol Vis Sci 2003, 44: 3170-3177.